Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients
Background: Carfilzomib improves the prognosis of multiple myeloma (MM) patients but significantly increases cardiovascular toxicity. The timing and effect of Carfilzomib therapy on the left ventricular function is still under investigation. We sought to assess the echocardiographic systo-diastolic...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021-04-01
|
| Edice: | Frontiers in Cardiovascular Medicine |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.645678/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
